Search results (16)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
OCION Funding Scheme: In conversation with David Church and Luciana Gneo
10 May 2024
The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology. We sat down with 2023 awardees, David Church and Luciana Gneo, to discuss what research the fund will enable them to carry out.
Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
17 October 2023
Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.
Predicting early recurrence of pancreatic cancer
3 May 2022
Dr Daniel Hughes and colleagues identify NUDT15 as a potential biomarker for pancreatic cancer recurrence following surgery.
How Oxford has shaped cancer science
4 February 2022
As part of World Cancer Day 2022 we are diving into 10 of Oxford’s most impactful historical and modern contributions to the field of cancer science and treatment. Read more about what Oxford researchers have done to shape this ever-important area of medical science.
Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
15 September 2021
A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.
NCITA Publishes Comment Article in the British Journal of Cancer
16 August 2021
Read their introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers.
New funding for early diagnosis research using platelets
30 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Finding extracellular vesicle biomarkers for oesophageal cancer early detection
22 February 2021
Prof Deborah Goberdhan’s lab is investigating extracellular vesicles and the proteins they express as potential biomarkers for the progression from Barrett’s Oesophagus to oesophageal cancer
Detecting for multiple cancers in one simple test
19 February 2021
Prof. Jason Davis is working alongside clinicians to introduce his biomarker assays into the clinic. Using a range of electroanalytical methods, together with electrode arrays and microfluidics, the platform has the potential to test for many types of cancers all at once, and at an earlier, pre-symptomatic stage.
Understanding how cancer arises from infected tissue
11 February 2021
Dr Francesco Boccellato is investigating the mechanisms behind the pre-cancerous condition known as atrophic gastritis. This may help to identify those who may have cancer, as well as find new ways to prevent cancer from progressing.
Detecting myeloma earlier
8 February 2021
Several research projects are underway in Oxford focusing on different points in the clinical care pathway to improve myeloma early detection.
Following the cancer metabolomic breadcrumb trail
1 February 2021
By analysing the metabolic molecules that tumour cells leave behind, Dr James Larkin is investigating the applications of metabolomics in the early detection of many cancers.
New sequencing methods for distinguishing DNA modifications
27 January 2021
Dr Chunxiao Song’s team have expanded their suite of bisulphite-free DNA modification sequencing methods to specifically and directly detect each of the four modifications made to the DNA base cytosine
SCALOP team discover new pancreatic cancer biomarker
27 November 2020
The SCALOP clinical trial team have uncovered a new therapeutic target for locally advanced pancreatic cancer. Read more about it and the next steps for the SCALOP-2 trial.
The search for pancreatic cancer biomarkers
23 November 2020
Nuffield Department of Population Health researchers are using the China Kadoorie Biobank to identify potential protein biomarkers in the blood that could be used to predict the presence or development of pancreatic cancer
Detecting pancreatic cancer through blood tests
9 November 2020
The Song Lab recently developed an effective and accurate way of detecting cancer biomarkers in the blood. Now, they are looking at the application of TAPS technology in pancreatic cancer